Company news: Rua Bioscience; Elixinol; Emyria; Cann Global; Health House; New Zealand Natural Fibres by Martin Lane December 22, 2021April 29, 2024 Rua Bioscience Rua Bioscience has had its first product approved by New Zealand’s Medicinal Cannabis Agency, […]
Company news: MGC Pharma/Extrax; Epsilon; Auscann; Roots; TSN; Emyria by cannabiz team December 16, 2021April 29, 2024
Company news: Rua Bioscience; Emyria; InhaleRx; Cannasouth; Roots: Creso Pharma; Epsilon by cannabiz team December 2, 2021April 29, 2024
Emyria raises A$5m to accelerate drug development and registration programs by Martin Lane November 22, 2021April 29, 2024
Company news: Cann Group; Releaf Group; Elixinol Wellness; Cronos Australia; Auscann; Zelira; Emyria; Incannex by cannabiz team October 21, 2021April 29, 2024
Emyria selected to join Palantir’s foundry builders program by Martin Lane October 8, 2021April 29, 2024
Company news: Bod Australia; Zelira Therapeutics; Creso Pharma; Emyria; AusCann; Allied Corp by Martin Lane September 23, 2021April 26, 2024
Company news: MGC Pharma; Emyria; ECS Botanics; Rua Bioscience; AusCann; Cannasouth; Cronos; Althea by Martin Lane September 2, 2021April 26, 2024
Company news: Bod; Emyria; Cann Group; Health House; Releaf Clinics; Creso Pharma; Greenfern; Medlab by Martin Lane August 26, 2021April 26, 2024
